Fast Five Quiz: Hepatitis B Epidemiology and Prevention

George Y. Wu, MD, PhD


March 03, 2020

Certain individuals should be tested for their response to HBV vaccination 1-2 months after the last vaccine dose; these include healthcare workers, sexual partners of those with chronic HBV, patients on chronic hemodialysis, and immunocompromised patients (eg, patients with HIV).

HBV vaccines can be administered as a three-dose series at 0, 1, and 6 months (with or without concurrent hepatitis A vaccine). Alternatively, combination hepatitis A and B vaccine utilizing a four-dose regimen at 0, 7, and 21-30 days and 12 months is available for adults. A two-dose series at 0 and 1 month is another available option for adults.

A double dose of the vaccine series is recommended for immunocompromised individuals (eg, patients with cirrhosis).

Learn more about the prevention of hepatitis B virus.

For additional information, refer to the American Association for the Study of Liver Diseases practice guidelines.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.